Chiron Corporation and Global Alliance for TB Drug Development Agree on License of PA-824 Compound for New Tuberculosis Therapeutics

Author: Global Alliance for TB Drug Development, Published on: 1 February 2002

Read the full post here

Related companies: Chiron